CIRARA in Large Hemispheric Infarction Analyzing Modified Rankin Scale (mRS) and Mortality (CHARM) "CHARM"

Not yet recruiting

Phase 3 Results N/A

Summary of Purpose

This study evaluates the use of the investigational drug CIRARA versus placebo in patients with a large hemispheric infarction.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 9 August 2016.

1 Feb 2017 12 Jul 2016 1 May 2019 1 Feb 2020 1 Aug 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

  • Remedy Pharmaceuticals, Inc.